226 related articles for article (PubMed ID: 12609848)
1. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth.
Yan X; Lin Y; Yang D; Shen Y; Yuan M; Zhang Z; Li P; Xia H; Li L; Luo D; Liu Q; Mann K; Bader BL
Blood; 2003 Jul; 102(1):184-91. PubMed ID: 12609848
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-kappaB activation.
Bu P; Gao L; Zhuang J; Feng J; Yang D; Yan X
Mol Cancer Ther; 2006 Nov; 5(11):2872-8. PubMed ID: 17121934
[TBL] [Abstract][Full Text] [Related]
3. A novel antibody AA98 V(H)/L directed against CD146 efficiently inhibits angiogenesis.
Lin Y; Wu X; Shen Y; Bu P; Yang D; Yan X
Anticancer Res; 2007; 27(6B):4219-24. PubMed ID: 18225593
[TBL] [Abstract][Full Text] [Related]
4. Structure basis for AA98 inhibition on the activation of endothelial cells mediated by CD146.
Chen X; Yan H; Liu D; Xu Q; Duan H; Feng J; Yan X; Xie C
iScience; 2021 May; 24(5):102417. PubMed ID: 33997697
[TBL] [Abstract][Full Text] [Related]
5. Identification and functional assessment of endothelial P1H12.
Solovey AN; Gui L; Chang L; Enenstein J; Browne PV; Hebbel RP
J Lab Clin Med; 2001 Nov; 138(5):322-31. PubMed ID: 11709656
[TBL] [Abstract][Full Text] [Related]
6. Synergistic killing effect between vorinostat and target of CD146 in malignant cells.
Ma X; Liu J; Wu J; Yan X; Wu P; Liu Y; Li S; Tian Y; Cao Y; Chen G; Meng L; Xu G; Wang S; Lu Y; Ma D; Zhou J
Clin Cancer Res; 2010 Nov; 16(21):5165-76. PubMed ID: 20884621
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
8. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
Yeh CH; Peng HC; Yang RS; Huang TF
Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
[TBL] [Abstract][Full Text] [Related]
9. Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization.
Zheng C; Qiu Y; Zeng Q; Zhang Y; Lu D; Yang D; Feng J; Yan X
Int J Biochem Cell Biol; 2009 Nov; 41(11):2163-72. PubMed ID: 19782948
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry.
Zhang R; Chen X; Chen S; Tang J; Chen F; Lin Y; Reinach PS; Yan X; Tu L; Duan H; Qu J; Hou Q
Cell Oncol (Dordr); 2022 Aug; 45(4):557-572. PubMed ID: 35716258
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
[TBL] [Abstract][Full Text] [Related]
12. CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis.
Jiang T; Zhuang J; Duan H; Luo Y; Zeng Q; Fan K; Yan H; Lu D; Ye Z; Hao J; Feng J; Yang D; Yan X
Blood; 2012 Sep; 120(11):2330-9. PubMed ID: 22718841
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting CD146 by its Monoclonal Antibody AA98 Improves Radiosensitivity of Cervical Cancer Cells.
Cheng H
Med Sci Monit; 2016 Sep; 22():3328-33. PubMed ID: 27647179
[TBL] [Abstract][Full Text] [Related]
14. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion.
Bardin N; Anfosso F; Massé JM; Cramer E; Sabatier F; Le Bivic A; Sampol J; Dignat-George F
Blood; 2001 Dec; 98(13):3677-84. PubMed ID: 11739172
[TBL] [Abstract][Full Text] [Related]
15. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
16. CD146: biosynthesis and production of a soluble form in human cultured endothelial cells.
Bardin N; Francès V; Combes V; Sampol J; Dignat-George F
FEBS Lett; 1998 Jan; 421(1):12-4. PubMed ID: 9462829
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability.
Corada M; Zanetta L; Orsenigo F; Breviario F; Lampugnani MG; Bernasconi S; Liao F; Hicklin DJ; Bohlen P; Dejana E
Blood; 2002 Aug; 100(3):905-11. PubMed ID: 12130501
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
[TBL] [Abstract][Full Text] [Related]
19. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
20. The role of CD146 (Mel-CAM) in biology and pathology.
Shih IM
J Pathol; 1999 Sep; 189(1):4-11. PubMed ID: 10451481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
